260 related articles for article (PubMed ID: 29673080)
1. Systemic sclerosis and malignancy.
Sargin G; Senturk T; Cildag S
Int J Rheum Dis; 2018 May; 21(5):1093-1097. PubMed ID: 29673080
[TBL] [Abstract][Full Text] [Related]
2. Determinants of morbidity and mortality of systemic sclerosis in Canada.
Al-Dhaher FF; Pope JE; Ouimet JM
Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and outcome of Thai patients with scleroderma renal crisis: a disease duration-matched case control study.
Wangkaew S; Lertthanaphok S; Puntana S; Noppakun K
Int J Rheum Dis; 2017 Oct; 20(10):1562-1571. PubMed ID: 28752678
[TBL] [Abstract][Full Text] [Related]
4. Malignancies associated with systemic sclerosis.
Szekanecz É; Szamosi S; Horváth Á; Németh Á; Juhász B; Szántó J; Szücs G; Szekanecz Z
Autoimmun Rev; 2012 Oct; 11(12):852-5. PubMed ID: 22410174
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Laboratory Characteristics and Mortality in Korean Patients with Systemic Sclerosis: A Nationwide Multicenter Retrospective Cohort Study.
Moon KW; Lee SS; Lee YJ; Jun JB; Yoo SJ; Ju JH; Chang SH; Choi IA; Kang TY; Lee EB; Lee SG
J Rheumatol; 2018 Aug; 45(9):1281-1288. PubMed ID: 30008455
[TBL] [Abstract][Full Text] [Related]
6. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
[TBL] [Abstract][Full Text] [Related]
7. Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran.
Poormoghim H; Andalib E; Jalali A; Ghaderi A; Ghorbannia A; Mojtabavi N
Rheumatol Int; 2016 Jul; 36(7):925-34. PubMed ID: 27061806
[TBL] [Abstract][Full Text] [Related]
8. Anti-PM-Scl antibody in patients with systemic sclerosis.
Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome.
Alharbi S; Ahmad Z; Bookman AA; Touma Z; Sanchez-Guerrero J; Mitsakakis N; Johnson SR
J Rheumatol; 2018 Oct; 45(10):1406-1410. PubMed ID: 30008448
[TBL] [Abstract][Full Text] [Related]
10. Mortality in the Waikato Hospital Systemic Sclerosis Cohort.
Ooi C; Solanki K; Lao C; Frampton C; White D
Int J Rheum Dis; 2018 Jan; 21(1):253-260. PubMed ID: 28580628
[TBL] [Abstract][Full Text] [Related]
11. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
[TBL] [Abstract][Full Text] [Related]
12. Mortality and causes of death in a Swedish series of systemic sclerosis patients.
Hesselstrand R; Scheja A; Akesson A
Ann Rheum Dis; 1998 Nov; 57(11):682-6. PubMed ID: 9924211
[TBL] [Abstract][Full Text] [Related]
13. Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis.
Simeon CP; Armadans L; Fonollosa V; Vilardell M; Candell J; Tolosa C; Mearin F; Rodrigo MJ; Solans R; Lima J; Sampol G
Ann Rheum Dis; 1997 Dec; 56(12):723-8. PubMed ID: 9496151
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study.
Ghrénassia E; Avouac J; Khanna D; Derk CT; Distler O; Suliman YA; Airo P; Carreira PE; Foti R; Granel B; Berezne A; Cabane J; Ingegnoli F; Rosato E; Caramaschi P; Hesselstrand R; Walker UA; Alegre-Sancho JJ; Zarrouk V; Agard C; Riccieri V; Schiopu E; Gladue H; Steen VD; Allanore Y
J Rheumatol; 2014 Jan; 41(1):99-105. PubMed ID: 24293584
[TBL] [Abstract][Full Text] [Related]
15. Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database.
Morgan ND; Shah AA; Mayes MD; Domsic RT; Medsger TA; Steen VD; Varga J; Carns M; Ramos PS; Silver RM; Schiopu E; Khanna D; Hsu V; Gordon JK; Gladue H; Saketkoo LA; Criswell LA; Derk CT; Trojanowski MA; Shanmugam VK; Chung L; Valenzuela A; Jan R; Goldberg A; Remmers EF; Kastner DL; Wigley FM; Gourh P; Boin F
Medicine (Baltimore); 2017 Dec; 96(51):e8980. PubMed ID: 29390428
[TBL] [Abstract][Full Text] [Related]
16. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
Tyndall AJ; Bannert B; Vonk M; Airò P; Cozzi F; Carreira PE; Bancel DF; Allanore Y; Müller-Ladner U; Distler O; Iannone F; Pellerito R; Pileckyte M; Miniati I; Ananieva L; Gurman AB; Damjanov N; Mueller A; Valentini G; Riemekasten G; Tikly M; Hummers L; Henriques MJ; Caramaschi P; Scheja A; Rozman B; Ton E; Kumánovics G; Coleiro B; Feierl E; Szucs G; Von Mühlen CA; Riccieri V; Novak S; Chizzolini C; Kotulska A; Denton C; Coelho PC; Kötter I; Simsek I; de la Pena Lefebvre PG; Hachulla E; Seibold JR; Rednic S; Stork J; Morovic-Vergles J; Walker UA
Ann Rheum Dis; 2010 Oct; 69(10):1809-15. PubMed ID: 20551155
[TBL] [Abstract][Full Text] [Related]
17. [Cancers in systemic sclerosis : risk factors, impact on survival and literature review].
Catano J; Guedon A; Riviere S; Carrat F; Mahevas T; Fain O; Mekinian A
Rev Med Interne; 2019 Oct; 40(10):637-644. PubMed ID: 31255252
[TBL] [Abstract][Full Text] [Related]
18. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
van den Hoogen F; Khanna D; Fransen J; Johnson SR; Baron M; Tyndall A; Matucci-Cerinic M; Naden RP; Medsger TA; Carreira PE; Riemekasten G; Clements PJ; Denton CP; Distler O; Allanore Y; Furst DE; Gabrielli A; Mayes MD; van Laar JM; Seibold JR; Czirjak L; Steen VD; Inanc M; Kowal-Bielecka O; Müller-Ladner U; Valentini G; Veale DJ; Vonk MC; Walker UA; Chung L; Collier DH; Ellen Csuka M; Fessler BJ; Guiducci S; Herrick A; Hsu VM; Jimenez S; Kahaleh B; Merkel PA; Sierakowski S; Silver RM; Simms RW; Varga J; Pope JE
Ann Rheum Dis; 2013 Nov; 72(11):1747-55. PubMed ID: 24092682
[TBL] [Abstract][Full Text] [Related]
19. Increased malignancies in our Waikato cohort of patients with systemic sclerosis.
Rees MS; Frampton C; White DHN; Solanki KK
Int J Rheum Dis; 2021 Apr; 24(4):555-561. PubMed ID: 33751804
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and incidence of systemic sclerosis in southern Sweden: population-based data with case ascertainment using the 1980 ARA criteria and the proposed ACR-EULAR classification criteria.
Andréasson K; Saxne T; Bergknut C; Hesselstrand R; Englund M
Ann Rheum Dis; 2014 Oct; 73(10):1788-92. PubMed ID: 23897770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]